Paul Ehrlich German physician and bacteriologist Date of Birth: 14.03.1854 Country: Germany

1. Biography of Paul Ehrlich
2. Early Career
3. Contributions to Medicine
4. Establishment of the Institute
5. Medical Breakthroughs
6. Contributions to Cancer Research
7. Later Life and Legacy

Biography of Paul Ehrlich

Paul Ehrlich (1854–1915) was a German physician and bacteriologist. He was born on March 14, 1854 in Silesia, Germany. Ehrlich studied at the universities of Breslau, Strasbourg, Freiburg, and Leipzig, and in 1878, he obtained his medical degree.

Early Career

After completing his education, Ehrlich began studying the distribution and fixation of various chemical substances in the human body. In 1878, he became an assistant at the Charité medical clinic in Berlin, where he conducted research on specific vital staining of different tissues and cells. He discovered that aniline dyes could be used to study respiration processes in intact tissues. His book "The Oxygen Requirements of the Organism" (Das Sauerstoff-Bedürfnis des Organismus, 1885) became a seminal work in the field of oxidative-reductive processes.

Contributions to Medicine

Ehrlich made significant contributions to various areas of medicine and biology. He discovered two different forms of leukocytes, established the role of bone marrow in blood formation, and identified the so-called mast cells. He conducted extensive research in the field of histology of the nervous system. In 1883, he developed a method for staining tuberculosis bacilli. From 1890 to 1895, Ehrlich worked under Robert Koch at the Institute of Infectious Diseases in Berlin, where he developed a method for determining the activity of antitoxic sera and studying the interaction between antigens and antibodies in vitro. He also formulated the theory of "side chains," which played a significant role in the development of immunology.

Establishment of the Institute

In 1896, Ehrlich founded and became the director of the Institute for Serum Research and Testing in Steglitz. In 1899, the institute relocated to Frankfurt-on-the-Main and was renamed the Institute of Experimental Therapy (now known as the Paul Ehrlich Institute). Ehrlich's primary focus during this period was finding ways to treat infectious diseases using chemical substances that could suppress the activity of disease-causing agents.

Medical Breakthroughs

Ehrlich introduced the use of methylene blue as a treatment for four-day malaria and proposed the use of trypan red for treating trypanosomiasis. His groundbreaking work on treating syphilis with organic arsenic compounds was of particular importance. In 1907, Ehrlich announced the discovery of arsphenamine (a derivative of arsenobenzene), an effective treatment for syphilis, which he named "Salvarsan" (from Latin "salvatio," meaning salvation). The substance is also known as "preparation 606" because it was the 606th compound tested by Ehrlich. Soon after, neosalvarsan, or "preparation 914," was also developed.

Contributions to Cancer Research

Ehrlich's research extended to malignant tumors. He developed several methods for experimentally inducing tumors in animals and established the occurrence of immune reactions after their regression. Ehrlich was awarded the Liebig Medal and was elected an honorary member of the German Chemical Society.

Later Life and Legacy

Paul Ehrlich passed away on August 20, 1915, in Bad Homburg, Germany. His contributions to medicine, immunology, and cancer research have had a lasting impact on the field. He was awarded the Nobel Prize in Physiology or Medicine in 1908, jointly with Ilya Mechnikov, for their work in immunology. Ehrlich's pioneering research laid the foundation for many advancements in medical science.